News Conference News TCT 2023 ‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big Todd Neale October 25, 2023
News Conference News TCT 2023 Watchman, Amulet LAAO Devices Have Similar Leak Rates at About 1 Year Todd Neale October 25, 2023
News Conference News TCT 2023 WATCH-TAVR: Adding LAAO to TAVI No Worse Than TAVI Alone Todd Neale October 24, 2023
News Conference News TCT 2023 OCT, IVUS Both Seem to Be Good Options for Complex Coronary Lesions Todd Neale October 23, 2023
News Daily News Earlier Extraction for Cardiac Device Infections Tied to Lower Mortality Todd Neale October 20, 2023
News Conference News HFSA 2023 Innovation in Heart Donation, Preservation Set to Shake Up Allocation Todd Neale October 18, 2023
News Daily News Radial Access Is Safe, Effective for Peripheral Interventions: R2P Registry Todd Neale October 16, 2023
News Conference News HFSA 2023 REBALANCE-HF Uncovers HFpEF Group That Responds to Splanchnic Nerve Ablation Todd Neale October 11, 2023
News Conference News HFSA 2023 Semaglutide Works Across LVEF Range: STEP-HFpEF Analysis Todd Neale October 11, 2023
News Daily News Positive Phase III Results Bring Excitement for Novel PET Imaging Tracer Todd Neale October 10, 2023
News Daily News Similar Outcomes With Enteric-Coated and Uncoated Aspirin: ADAPTABLE Todd Neale October 06, 2023
News Daily News Cardiology Society Leaders Expand on Vision for New Medical Board Todd Neale October 05, 2023
News Daily News To Curb Secondary Event Risk, Go ‘Granular’ With Causes of TIA, Minor Stroke Todd Neale October 03, 2023
News Daily News CRT With His-Purkinje Conduction System Pacing Succeeds in Pilot RCT Todd Neale September 20, 2023
News Daily News Aggressive Lipid-Lowering Very Unlikely to Hurt the Brain: AHA Todd Neale September 19, 2023
News Daily News Slight Declines in Kidney Function Portend CV Trouble for Young Adults Todd Neale September 18, 2023
News Daily News Prescribing a Generic for CVD? Plan, Drug Type, and Condition Impact Availability Todd Neale September 13, 2023
News Daily News Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle Todd Neale September 12, 2023
News Daily News Subclinical HFpEF Common in Patients Undergoing AF Ablation Todd Neale September 08, 2023